A detailed history of Brevan Howard Capital Management LP transactions in Merck & Co., Inc. stock. As of the latest transaction made, Brevan Howard Capital Management LP holds 11,267 shares of MRK stock, worth $1.12 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
11,267
Holding current value
$1.12 Million
% of portfolio
0.01%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$111.15 - $128.97 $1.25 Million - $1.45 Million
11,267 New
11,267 $1.28 Million
Q1 2024

May 15, 2024

BUY
$113.24 - $131.95 $7.78 Million - $9.07 Million
68,734 Added 227.98%
98,883 $13 Million
Q4 2023

Feb 14, 2024

BUY
$100.18 - $109.02 $3.02 Million - $3.29 Million
30,149 New
30,149 $3.29 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $252B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Brevan Howard Capital Management LP Portfolio

Follow Brevan Howard Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Brevan Howard Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Brevan Howard Capital Management LP with notifications on news.